Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Novartis
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Calithera Biosciences, Inc
Weill Medical College of Cornell University
University Health Network, Toronto
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
UNICANCER
UNICANCER
UNICANCER
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Maryland, Baltimore
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Amgen
Dartmouth-Hitchcock Medical Center
AEterna Zentaris
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Pfizer
OHSU Knight Cancer Institute
The Cleveland Clinic
The Cleveland Clinic
University of Pittsburgh
AstraZeneca
Dana-Farber Cancer Institute
Novartis
Columbia University
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center